Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

H.  Lundbeck A/S hereby reports transactions  made by executives and persons and
legal  entities closely associated  to them with  shares in H.  Lundbeck A/S and
linked securities, cf. section 28a of the Danish Securities Trading Act.

The  list is  based on  reports received  by H.  Lundbeck A/S from the company's
executives today or yesterday.

Name:                                      Sven Håkan Björklund

Job position of the executive:                     Board member

ID code (ISIN code):                              DK 0010287234

Description of the security:                              Share

Nature of the transaction:                   Purchase of shares

Date of trading:                                 22 August 2011

Market on which the trading was effected: Nasdaq OMX Copenhagen

Number of traded securities:                       1,662 shares

Market price of securities traded:                  DKK 198,941

Persons  or entities under an obligation to report are defined as members of the
Executive   Management  and  the  Supervisory  Board  of  H.  Lundbeck  A/S  and
persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

  * spouse or cohabitant
  * children below the age of 18
  * legal entities in which the insider has a controlling
    influence

The content of this release will have no influence on the Lundbeck Group's
financial expectations for 2011.


Lundbeck contacts

Investors:                           Media:



Palle Holm Olesen                    Mads Kronborg

Chief Specialist, Investor Relations Media Relations Manager

palo@lundbeck.com                    mavk@lundbeck.com

+45 36 43 24 26                      +45 36 43 28 51



Magnus Thorstholm Jensen             Simon Mehl Augustesen

Investor Relations Officer           International Media Specialist

matj@lundbeck.com                    smeh@lundbeck.com

+45 36 43 38 16                      +45 36 43 49 80



Jacob Tolstrup

Vice President

jtl@lundbeck.com

+1 847 282 5713


About Lundbeck
H.  Lundbeck  A/S  (LUN.CO,  LUN  DC,  HLUKY) is an international pharmaceutical
company  highly committed to improving the  quality of life for people suffering
from  central  nervous  system  (CNS)  disorders.  For this purpose, Lundbeck is
engaged  in  the  research,  development,  production,  marketing  and  sale  of
pharmaceuticals  across  the  world.  The  company's  products  are  targeted at
disorders  such as depression and anxiety, schizophrenia, insomnia, epilepsy and
Huntington's, Alzheimer's and Parkinson's diseases.

Lundbeck  was founded  in 1915 by  Hans Lundbeck  in Copenhagen,  Denmark. Today
Lundbeck  employs approximately 5,900 people  worldwide. Lundbeck is  one of the
world's  leading pharmaceutical companies working  with CNS disorders. In 2010,
the company's revenue was DKK 14.8 billion (approximately EUR 2.0 billion or USD
2.6 billion). For more information, please visit www.lundbeck.com.




[HUG#1540141]